Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3)

BACKGROUND: Fatty liver is a reversible status, but also an origin stage to develop to other metabolic syndromes, such as diabetes and heart disease that threatens public health worldwide. Ascorbate deficiency is reported to be correlated with increasing risks for metabolic syndromes, but whether as...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Nutr Metab (Lond)
Päätekijät: Xu, Yingying, Wu, Yuhang, Xiong, Yue, Tao, Jiawang, Pan, Tingcai, Tan, Shenglin, Gao, Ge, Chen, Yan, Abbas, Nasir, Getachew, Anteneh, Zhuang, Yuanqi, You, Kai, Yang, Fan, Li, Yin-xiong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057613/
https://ncbi.nlm.nih.gov/pubmed/32158492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12986-020-0431-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia